Zobrazeno 1 - 10
of 626
pro vyhledávání: '"4CMenB"'
Autor:
Phung Nguyen The Nguyen, Pham Quang Thai, Tran Minh Dien, Do Thien Hai, Vo Thi Trang Dai, Nguyen Huy Luan, Gaurav Mathur, Selim Badur, Doan Minh Truyen, Nguyen Hoan Le Minh
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 423-437 (2024)
Abstract An advisory board meeting was held with experts in Vietnam (Hanoi, August 2022), to review the evidence on invasive meningococcal disease (IMD) epidemiology, clinical management, and meningococcal vaccines to reach a consensus on recommendat
Externí odkaz:
https://doaj.org/article/899ec0a8276d4794a22f3d996718b33f
Autor:
Adriana Efron, Alessandro Brozzi, Alessia Biolchi, Margherita Bodini, Maria Giuliani, Silvia Guidotti, Federico Lorenzo, María Alicia Moscoloni, Alessandro Muzzi, Florencia Nocita, Mariagrazia Pizza, Rino Rappuoli, Sara Tomei, Gabriela Vidal, Carla Vizzotti, Josefina Campos, Cecilia Sorhouet Pereira
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Meningococcal (Neisseria meningitidis) serogroup B (MenB) strain antigens are diverse and a limited number of strains can be evaluated using the human serum bactericidal antibody (hSBA) assay. The genetic Meningococcal Antigen Typing System (gMATS) w
Externí odkaz:
https://doaj.org/article/632b67600d7841ac9afc9f3eeb4db909
Autor:
Véronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, Terry Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide. Real-world evidence (RWE) from the last decade confirms
Externí odkaz:
https://doaj.org/article/380746a45f9448248f21e680320ecf7a
Autor:
Paolo Bonanni, Stefano Castagna, Giovanni Gabutti, Sandro Giuffrida, Federico Marchetti, Rocco Russo, Rosa Prato, Francesco Vitale
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTVaccine co-administration is a useful strategy for improving vaccine coverage and adherence. In Italy, an update to the national immunization program (NIP) in 2023 included recommendations for co-administration of pediatric vaccines, includin
Externí odkaz:
https://doaj.org/article/3a3fb4a75c544c598747f410bb1c0353
Publikováno v:
mSphere, Vol 9, Iss 6 (2024)
ABSTRACT Neisseria meningitidis serogroup B (NmB) strains have diverse antigens, necessitating methods for predicting meningococcal serogroup B (MenB) vaccine strain coverage. The genetic Meningococcal Antigen Typing System (gMATS), a correlate of MA
Externí odkaz:
https://doaj.org/article/a65676e8785b4f98b645a1d1c52ac211
Autor:
Ray Borrow, Federico Martinón-Torres, Véronique Abitbol, Anar Andani, Scott Preiss, Alessandro Muzzi, Laura Serino, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 738-748 (2023)
Introduction Neisseria meningitidis serogroup B (NmB) antigens are inherently diverse with variable expression among strains. Prediction of meningococcal B (MenB) vaccine effectiveness therefore requires an assay suitable for use against large panels
Externí odkaz:
https://doaj.org/article/4e1c2a33874d4f68b50c1a9a666b28e7
Autor:
Gary S. Marshall, Victoria Abbing-Karahagopian, Helen S. Marshall, Silvia Cenci, James H. Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 530-544 (2023)
Introduction Neisseria meningitidis causes invasive meningococcal disease and, globally, significant morbidity, with serogroup B (MenB) being the most common cause of endemic disease and outbreaks in several regions. Extensive use of the four-compone
Externí odkaz:
https://doaj.org/article/5daed63073d345389ee6f909c76924d7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
George Kassianos, Osamah Barasheed, Victoria Abbing-Karahagopian, Mansour Khalaf, Serdar Ozturk, Angelika Banzhoff, Selim Badur
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 9, Pp 2193-2219 (2023)
Abstract Recombinant vaccines against invasive meningococcal disease due to Neisseria meningitidis serogroup B (MenB) have shown substantial impact in reducing MenB disease in targeted populations. 4CMenB targets four key N. meningitidis protein anti
Externí odkaz:
https://doaj.org/article/8f7fc635bd144f34931b69271a4c2213
Autor:
Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTInvasive meningococcal disease (IMD) is a life-threatening disease caused by meningococcal serogroups A, B, C, W, X, and Y, of which B and W are most common in Argentina. The 4-component meningococcal serogroup B (4CMenB) vaccine contains thr
Externí odkaz:
https://doaj.org/article/c66b3266ecfb48d0875e728f67f19c46